[1]林诗群,尹心恺,陈有信,等.视盘周围脉络膜肥厚综合征研究进展[J].眼科新进展,2023,43(5):417-420.[doi:10.13389/j.cnki.rao.2023.0084]
　LIN Shiqun,YIN Xinkai,CHEN Youxin,et al.Research progress in the peripapillary pachychoroid syndrome[J].Recent Advances in Ophthalmology,2023,43(5):417-420.[doi:10.13389/j.cnki.rao.2023.0084]
点击复制

视盘周围脉络膜肥厚综合征研究进展/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
43卷
期数:
2023年5期
页码:
417-420
栏目:
文献综述
出版日期:
2023-05-05

文章信息/Info

Title:
Research progress in the peripapillary pachychoroid syndrome
作者:
林诗群; 尹心恺; 陈有信; 戴荣平
100730　北京市，中国医学科学院，北京协和医学院，北京协和医院眼科，中国医学科学院眼底病重点实验室（林诗群，陈有信，戴荣平）；518000　广东省深圳市，暨南大学附属深圳爱尔眼科医院（尹心恺）
Author(s):
LIN Shiqun1; YIN Xinkai2; CHEN Youxin1; DAI Rongping1
1.Key Laboratory of Ocular Fundus Diseases，Department of Ophthalmology，Peking Union Medical College Hospital，Chinese Academy of Medical Science & Peking Union Medical College，Beijing 100730，China
2.Shenzhen Aier Eye Hospital Affiliated to Jinan University，Shenzhen 518000，Guangdong Province，China
关键词:
视盘周围脉络膜肥厚综合征; 临床特征; 发病机制
Keywords:
peripapillary pachychoroid syndrome;  clinical features;  pathogenesis
分类号:
R774.1
DOI:
10.13389/j.cnki.rao.2023.0084
文献标志码:
A
摘要:
视盘周围脉络膜肥厚综合征是近年来提出的一个相对较新的概念，描述了一类以视盘周围脉络膜增厚及脉络膜大血管层扩张为特点的视网膜脉络膜疾病，其特征为局限性或弥漫性脉络膜增厚、脉络膜最厚区域位于视盘周围、视盘周围视网膜层间积液、黄斑区神经上皮脱离合并视网膜色素上皮脱离。本文对视盘周围脉络膜肥厚综合征的临床特征、发病机制、诊断和鉴别诊断以及治疗等进行综述。
Abstract:
The peripapillary pachychoroid syndrome is a relatively novel concept that has been put forward in recent years, which describes a type of retinal/choroid disease characterized by choroidal thickening around the optic disc and dilation of the choroidal macrovascular layer. It is characterized by localized or diffuse choroidal thickening, the thickest choroidal area around the optic disc, intraretinal fluid around the optic disc, and neuroepithelial detachment in the macular region together with pigmentary epithelium detachment of the retina. The clinical features, pathogenesis, diagnosis, differential diagnosis, and treatment of peripapillary pachychoroid syndrome are reviewed in this paper.

参考文献/References:

［1］　BALARATNASINGAM C，LEE W K，KOIZUMIOIZUMI H，DANSINGANI K，INOUE M，FREUND K B.Polypoidal choroidal vasculopathy:a distinct disease or manifestation of many? ［J］.Retina，2016，36(1):1-8.
［2］　KUMAR V，AZAD S V，VERMA S，SURVE A，VOHRA R，VENKATESH P.Peripapillary pachychoroid syndrome:new insights［J］.Retina,2022，42(1):80-87.
［3］　PAUTLER S E，BROWNING D J.Isolated posterior uveal effusion:expanding the spectrum of the uveal effusion syndrome ［J］.Clin Ophthalmol,2015，9:43-49.
［4］　PHASUKKIJWATANA N，FREUND K B，DOLZ-MARCO R，AL-SHEIKH M，KEANE P A，EGAN C A，et al.Peripapillary pachychoroid syndrome［J］.Retina,2018，38(9):1652-1667.
［5］　MARGOLIS R，SPAIDE R F.A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes ［J］.Am J Ophthalmol,2009，147(5):811-815.
［6］　SHIN J W，SHIN Y U，LEE B R.Choroidal thickness and volume mapping by a six radial scan protocol on spectral-domain optical coherence tomography［J］.Ophthalmology,2012,119(5):1017-1023.
［7］　GUYER D R，YANNUZZI L A，SLAKTER J S，SORENSON J A，HO A，ORLOCK D.Digital indocyanine green videoangiography of central serous chorioretinopathy［J］.Arch Ophthalmol,1994，112(8):1057-1062.
［8］　ALONSO-MARYIN B，DE-LUCAS-VIEJO B，GIMENO-CARRERO M，FERRO-OSUNA M，SAMBRICIO J.Diagnosis by multimodal imaging in peripapillary pachychoroid syndrome:a case report［J］.Arch Soc Esp Oftalmol (Engl Ed),2020，95(5):248-253.
［9］　XU D，GARG E，LEE K，SAKURADA Y，AMPHORNPHRUET A，PHASUKKIJWATANA N，et al.Long-term visual and anatomic outcomes of patients with peripapillary pachychoroid syndrome［J］.Br J Ophthalmol,2022，106(4):576-581.
［10］　IOVINO C，PEIRETTI E，TATTI F，QUERQUES G，BORRELLI E，SACCONI R，et al.Photodynamic therapy as a treatment option for peripapillary pachychoroid syndrome:a pilot study［J］.Eye (Lond),2022，36(4):716-723.
［11］　BAREQUET D，IGLICKI M，MESHI A，LOEWENSTEIN A，GOLDSTEIN M，ZUR D.Acquired vitelliform lesions -a novel finding in eyes with peripapillary pachychoroid syndrome［J］.Retina，2022，42(5):949-956.
［12］　MONTERO HERNANDEZ J，REMOLI SARGUES L，MONFERRER ADSUARA C，CASTRO NAVARRO V，NAVARRO PALOP C，CERVERA TAULET E.Peripapillary pachychoroid neovasculopathy:a novel entity［J］.Eur J Ophthalmol，2022，32(1):NP149-NP153.
［13］　CHEUNG C M G，LEE W K，KOIZUMI H，DANSINGANI K，LAI T Y Y，FREUND K B.Pachychoroid disease［J］.Eye (Lond)，2019，33(1):14-33.
［14］　SIEDLECKI J，SCHWORM B，PRIGLINGER S G.The pachychoroid disease spectrum-and the need for a uniform classification system［J］.Ophthalmol Retina，2019，3(12):1013-1015.
［15］　ERSOZ M G，ARF S，HOCAOGLU M，SAYMAN MUSLUBAS I，KARACORLU M.Indocyanine green angiography of pachychoroid pigment epitheliopathy［J］.Retina，2018，38(9):1668-1674.
［16］　IIDA T，KISHI S，HAGIMURA N，SHIMIZU K.Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy［J］.Retina，1999，19(6):508-512.
［17］　KOIZUMI H，YAMAGISHI T，YAMAZAKI T，KINOSHITA S.Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability［J］.Am J Ophthalmol，2013，155(2):305-313.
［18］　TSUJIKAWA A，OJIMA Y，YAMASHIRO K，OOTO S，TAMURA H，NAKAGAWA S，et al.Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography［J］.Retina，2010，30(5):801-809.
［19］　SPAIDE R F，LEDESMA-GIL G，GEMMY CHEUNG C M.Intervortex venous anastomosis in pachychoroid-related disorders［J］.Retina，2021，41(5):997-1004.
［20］　MANSOURI K，MEDEIROS F A，MARCHASE N，TATHAM A J，AUERBACH D，WEINREB R N.Assessment of choroidal thickness and volume during the water drinking test by swept-source optical coherence tomography［J］.Ophthalmology，2013，120(12):2508-2516.
［21］　SHINOJIMA A，IWASAKI K，AOKI K，OGAWA Y，YANAGIDA R，YUZAWA M.Subfoveal choroidal thickness and foveal retinal thickness during head-down tilt［J］.Aviat Space Environ Med，2012，83(4):388-393.
［22］　GOVEYYO A，SARRAF D，SCIALDONE A.“Hide and seek” neurosensory retinal detachments in peripapillary pachychoroid syndrome associated with pulmonary arterial hypertension［J］.Retin Cases Brief Rep,2022，16(1):118-125.
［23］　NAGIA L，HUISINGH C，JOHNSTONE J，KLINE L B，CLARK M，GIRARD M J，et al.Peripapillary pachychoroid in nonarteritic anterior ischemic optic neuropathy［J］.Invest Ophthalmol Vis Sci，2016，57(11):4679-4685.
［24］　WARROW D J，HOANG Q V，FREUND K B.Pachychoroid pigment epitheliopathy［J］.Retina，2013，33(8):1659-1672.
［25］　LEE J H，PARK H Y，BAEK J，LEE W K.Alterations of the lamina cribrosa are associated with peripapillary retinoschisis in glaucoma and pachychoroid spectrum disease［J］.Ophthalmology，2016，123(10):2066-2076.
［26］　LEE W K，BAEK J，DANSINGANI K K，LEE J H，FREUND K B.Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal subfoveal choroidal thickness［J］.Retina，2016，36:S73-S82.
［27］　DANSINGANI K K，BALARATNASINGAM C，NAYSAN J，FREUND K B.En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography［J］.Retina,2016，36(3):499-516.
［28］　LIU Q，HEMARAT K，KAYSER D L，STEWART J M.A case of posterior uveal effusion syndrome masquerading as uveitis［J］.Retin Cases Brief Rep，2017，11:S124-S127.
［29］　FREUND K B，FINE H F.Pachychoroid disease［J］.Ophthalmic Surg Lasers Imaging Retina，2020,51(4):206-209.
［30］　VAN DIJK E H C，FAUSER S，BREUKINK M B，BLANCO-GARAVITO R，GROENEWOUD J M M，KEUNEN J E E，et al.Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy:the place trial［J］.Ophthalmology，2018，125(10):1547-1555.
［31］　VAN RIJSSEN T J，VAN DIJK E H C，YZER S，OHNO-MATSUI K，KEUNEN J E E，SCHLINGEMANN R O，et al.Central serous chorioretinopathy:towards an evidence-based treatment guideline［J］.Prog Retin Eye Res，2019，73:100770.
［32］　YZER S，POTHOF A，MARTINEZ J，BEHAR-COHEN F F.Treatment of peripapillary pachychoroid syndrome［J］.Invest Ophthalmol Vis Sci，2020，61(7):5255.

相似文献/References:

[1]王莎莎 汪昌运.正常眼压性青光眼的研究进展[J].眼科新进展,2013,33(10):000.
[2]任明玉 刘立民 高宇 高占国. 眼部上皮性囊肿组织病理学分类和临床特点[J].眼科新进展,2014,34(3):272.
[3]罗晓阳,张良,孟倩丽,等.恶性青光眼的临床特征和危险因素分析[J].眼科新进展,2016,36(9):835.[doi:10.13389/j.cnki.rao.2016.0223]
　LUO Xiao-Yang,ZHANG Liang,MENG Qian-Li,et al.Analysis of clinical characteristics and risk factors of malignant glaucoma[J].Recent Advances in Ophthalmology,2016,36(5):835.[doi:10.13389/j.cnki.rao.2016.0223]
[4]李志强,刘桂琴,祝天辉,等.伴或不伴下直肌箝闭的trapdoor眼眶骨折的临床特征[J].眼科新进展,2016,36(10):953.[doi:10.13389/j.cnki.rao.2016.0255]
　LI Zhi-Qiang,LIU Gui-Qin,ZHU Tian-Hui,et al.Clinical features of orbital-floor trapdoor fracture with or without inferior rectus muscle incarceration[J].Recent Advances in Ophthalmology,2016,36(5):953.[doi:10.13389/j.cnki.rao.2016.0255]
[5]许领先,王晨光,苏冠方.急性黄斑旁中心中层视网膜病变研究进展[J].眼科新进展,2020,40(8):784.[doi:10.13389/j.cnki.rao.2020.0179]
　XU Lingxian,WANG Chenguang,SU Guanfang.Research progress on paracentral acute middle maculopathy[J].Recent Advances in Ophthalmology,2020,40(5):784.[doi:10.13389/j.cnki.rao.2020.0179]
[6]赵振,张晓玉,王慧瑾,等.无孢霉菌性角膜炎患者的临床特征及治疗转归[J].眼科新进展,2021,41(5):438.[doi:10.13389/j.cnki.rao.2021.0091]
　ZHAO Zhen,ZHANG Xiaoyu,WANG Huijin,et al.Clinical characteristics and treatment outcome of patients with nonsporulating molds keratitis[J].Recent Advances in Ophthalmology,2021,41(5):438.[doi:10.13389/j.cnki.rao.2021.0091]

备注/Memo

备注/Memo:
北京市自然科学基金-京津冀合作专项项目（编号：J200007）
更新日期/Last Update: 2023-05-05